Search results
With roots deeply planted in Canadian soil, and decades of experience navigating the complex Canadian healthcare system, we are your guide for strategic commercialization in Canada. We will help you seamlessly navigate entry to market, and improve patient outcomes. Learn how we can support you.
Jun 6, 2024 · Cencora, a wholesale drug company formerly known as AmerisourceBergen and the parent company of The Lash Group, announced in May 2024 that an unauthorized third party accessed its network and exfiltrated sensitive data.
Jun 14, 2024 · Innomar Strategies est une filiale du géant américain de la distribution de médicaments Cencora. Les données médicales et personnelles de patients d’Innomar Strategies – une importante...
Jun 14, 2024 · Medical and personal patient data from Innomar Strategies – a major Canadian pharmaceutical company – was stolen following an intrusion into the parent company’s computer system. Potential victims interviewed by La Presse did not know that this company had access to this sensitive information.
4 days ago · Cencora detected the cyberattack on February 21, 2024, and took immediate action to contain the attack and prevent further unauthorized access. The forensic investigation confirmed that a threat actor had exfiltrated data from its systems, including patient data provided by its clients for its patient support programs.
Innomar Strategies, a part of Cencora, is Canada’s leading patient support provider for specialty pharmaceuticals. We deliver end-to-end support solutions to improve product...
May 31, 2024 · U.S. pharmaceutical giant Cencora has disclosed that the February 2024 data breach leaked sensitive patient data, including diagnoses and medications. At least 15 pharmaceutical companies have informed over 500,000 individuals that their information was leaked.
